Skip to main content




South Korean companies offer employees COVID-19 vaccines at work

South Korean companies offer employees COVID-19 vaccines at work

FILE PHOTO: Women wearing protective masks talk behind a cordoned-off area of a Han river park amid the COVID-19 pandemic in Seoul, on Apr 29, 2021. (Photo: REUTERS/Kim Hong-Ji)

SEOUL: South Korea's large manufacturing employers have received permission from the country's health authorities to administer COVID-19 vaccines at in-house clinics, hoping to speed up inoculation of their employees.

The inoculation plans come amid the South Korean government's push to ramp up vaccinations after a slow start. South Korea has inoculated 15.3 million people, or about 30 per cent of its population, with at least one dose since it began administering vaccines in February.

Affiliates of the country's biggest conglomerate Samsung Group, including Samsung Electronics, Samsung Display and Samsung SDI, plan to offer vaccine doses to employees at work next month, the companies said on Tuesday.

Samsung affiliates plan to offer Moderna's COVID-19 vaccines for its office and production workers, as well as workers from suppliers in South Korea who sign up for doses.

READ: South Korea to loosen COVID-19 social distancing rules on Jul 1

READ: South Korea's SK bioscience to invest US$132 million to boost vaccine production

Other large companies registered to provide doses include chipmaker SK Hynix and panel maker LG Display, according to the companies. Under the plans only companies' own staff and stationed workers from suppliers are eligible for the vaccinations.

South Korea reported 595 new infections in the 24 hours up to midnight on Monday, bringing its tally to 156,167 cases, the Korea Disease Control and Prevention Agency said, with a death toll of 2,017.

BOOKMARK THIS: Our comprehensive coverage of the coronavirus outbreak and its developments

Download our app or subscribe to our Telegram channel for the latest updates on the coronavirus outbreak:

Source: Reuters/ga


Also worth reading